Inhibition of autoimmune encephalomyelitis by a tetracycline

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases

Liblau, R., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,111 · see citing works

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,056 · see citing works

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040 · see citing works

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · see citing works

MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES

González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984 · see citing works

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works

Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis

Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T. P., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 914 · see citing works

Glutamate excitotoxicity in a model of multiple sclerosis

Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 855 · see citing works

Matrix metalloproteinases and diseases of the CNS

Yong, V. W., Forsyth, P. A., Bell, R. B., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 635 · see citing works

Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

Storch, M., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 566 · see citing works

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547 · see citing works

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532 · see citing works

Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia

Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530 · see citing works

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467 · see citing works

Interleukin‐10 prevents experimental allergic encephalomyelitis in rats

Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367 · see citing works

The link between excitotoxic oligodendroglial death and demyelinating diseases

Matute, C., Alberdi, E. M., Domercq, M., Pérez‐Cerdá, F., Pérez‐Samartín, A., & Sánchez‐Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 346 · see citing works

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement

Piddlesden, S. J. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 288 · see citing works

Progress in determining the causes and treatment of multiple sclerosis

Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 275 · see citing works

Safety of long-term high-dose minocycline in the treatment of acne

Goulden, V., GLASS, D., & Cunliffe, W. J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06972.x · Cited by 218 · see citing works

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

Powers, J. M., & Moser, H. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00139.x · Cited by 208 · see citing works

Induction, binding specificity and function of human ICOS

Beier, K. C., Hutloff, A., Dittrich, A., Heuck, C. J., Rauch, A. M., Büchner, K., Ludewig, B., Ochs, H. D., Mages, H. W., & Kroczek, R. A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12 · Cited by 179 · see citing works

Matrix metalloproteinases in inflammatory demyelination

Kieseier, B. C., Seifert‐Held, T., Giovannoni, G., & Hartung, H. (1999) · Neurology · doi:10.1212/wnl.53.1.20 · Cited by 167 · see citing works

Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.

Greenwald, R. A., Moak, S. A., Ramamurthy, N. S., & Golub, L. M. (1992) · PubMed · Cited by 164 · see citing works

Interleukin‐12 induces interferon‐γ‐dependent switching of IgG alloantibody subclass

Gracie, J. A., & Bradley, J. A. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260605 · Cited by 156 · see citing works

Indictment of the microglia as the villain in multiple sclerosis

Sriram, S., & Rodriguez, M. (1997) · Neurology · doi:10.1212/wnl.48.2.464 · Cited by 148 · see citing works

Myelin Oligodendrocyte Glycoprotein Induces Experimental Autoimmune Encephalomyelitis in the “Resistant” Brown Norway Rat: Disease Susceptibility Is Determined by MHC and MHC-Linked Effects on the B Cell Response

Stefferl, A., Brehm, U., Storch, M. K., Lambracht‐Washington, D., Bourquin, C., Wonigeit, K., Lassmann, H., & Linington, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.40 · Cited by 143 · see citing works

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement

Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137 · see citing works

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors

Liedtke, W., Cannella, B., Mazzaccaro, R. J., Clements, J. M., Miller, K., Wucherpfenning, K. W., Gearing, A. J. H., & Raine, C. S. (1998) · Annals of Neurology · doi:10.1002/ana.410440110 · Cited by 128 · see citing works

Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells

Khoruts, A., Miller, S. D., & Jenkins, M. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5011 · Cited by 126 · see citing works

Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

Graesser, D., Mahooti, S., & Madri, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00275-7 · Cited by 88 · see citing works

Macrophage responses in inflammatory demyelinating neuropathies

Griffin, J. W., Stoll, G., Li, C. Y., Tyor, W. R., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270717 · Cited by 81 · see citing works

Treatment of Destructive Arthritic Disorders with MMP Inhibitors

Greenwald, R. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24734.x · Cited by 72 · see citing works

Rattlesnake Hunting Behavior: Correlations between Plasticity of Predatory Performance and Neuroanatomy

Kardong, K. V., & Berkhoudt, H. (1998) · Brain Behavior and Evolution · doi:10.1159/000006579 · Cited by 65 · see citing works

MINOCYCLINE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Alarcón, G. S. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70022-3 · Cited by 17 · see citing works

Interleukin‐10 is an Unequivocal Th2 Parameter in the Rat, whereas Interleukin‐4 is Not *

Vandebriel, R. J., Meredith, C., Scott, M. P., van Dijk, M., & Loveren, H. V. (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00804.x · Cited by 16 · see citing works

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights substrates of disability

Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2 · see citing works

The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2

Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2 · see citing works

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2

Minocycline: Far beyond an Antibiotic

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935 · see citing works

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology

Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821 · see citing works

Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases

Hu, J., den Steen, P. E. V., Sang, Q. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 798 · see citing works

Pathophysiology and pharmacologic treatment of acute spinal cord injury*1

Kwon, B. K. (2004) · The Spine Journal · doi:10.1016/j.spinee.2003.07.007 · Cited by 691 · see citing works

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., & Watkins, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.009 · Cited by 677 · see citing works

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649 · see citing works

Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D. W., Gill, S. E., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 555 · see citing works

The Promise of Minocycline in Neurology

Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518 · see citing works

Minocycline and Neurodegenerative Diseases

Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447 · see citing works

Minocycline treatment in acute stroke

Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A. M., Anca-Hershkowitz, M., & Sadeh, M. (2007) · Neurology · doi:10.1212/01.wnl.0000277487.04281.db · Cited by 443 · see citing works

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice.

Wells, J., Hurlbert, R., Fehlings, M., & Yong, W. V. (2003) · Brain : a journal of neurology · doi:10.1093/brain/awg178 · Cited by 437 · see citing works

Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury

Casha, S., Zygun, D., McGowan, M.-B., Bains, I., Yong, V. W., & Hurlbert, R. J. (2012) · Brain · doi:10.1093/brain/aws072 · Cited by 407 · see citing works

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

Wang, X., Zhu, S., Drozda, M., Zhang, W., Stavrovskaya, I. G., Cattaneo, E. F., Ferrante, R. J., Kristal, B. S., & Friedlander, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832501100 · Cited by 407 · see citing works

Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

Power, C., Henry, S. D., Bigio, M. R. D., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., & Peeling, J. (2003) · Annals of Neurology · doi:10.1002/ana.10553 · Cited by 363 · see citing works

The Yin and Yang of Microglia

Czéh, M., Gressèns, P., & Kaindl, A. M. (2011) · Developmental Neuroscience · doi:10.1159/000328989 · Cited by 323 · see citing works

Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury

Arvin, K. L., Han, B., Du, Y.-S., Lin, S.-Z., Paul, S. M., & Holtzman, D. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 323 · see citing works

Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease Models

Choi, Y., Kim, H., Shin, K. Y., Kim, E., Kim, M., Kim, H.-S., Park, C. H., Jeong, Y. H., Yoo, J., Lee, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301377 · Cited by 290 · see citing works

Minocycline as a Neuroprotective Agent

Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 280 · see citing works

NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora

Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080622 · Cited by 264 · see citing works

Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target

Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 266 · see citing works

The lung microbiome regulates brain autoimmunity

Hosang, L., Canals, R. C., van der Flier, F. J., Hollensteiner, J., Daniel, R., Flügel, A., & Odoardi, F. (2022) · Nature · doi:10.1038/s41586-022-04427-4 · Cited by 260 · see citing works

Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity

Takahashi, J., Giuliani, F., Power, C., Imai, Y., & Yong, V. W. (2003) · Annals of Neurology · doi:10.1002/ana.10519 · Cited by 256 · see citing works

Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria

Wang, J., Wei, Q., Wang, C., Hill, W., Hess, D. C., & Dong, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313629200 · Cited by 242 · see citing works

Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration

Bye, N., Habgood, M. D., Callaway, J. K., Malakooti, N., Potter, A., Kossmann, T., & Morganti-Kossmann, M. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.10.013 · Cited by 239 · see citing works

Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis

Howell, O. W., Rundle, J., Garg, A., Komada, M., Brophy, P., & Reynolds, R. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f3a5b1 · Cited by 222 · see citing works

Neuroprotection by tetracyclines

Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205 · see citing works

Minocycline Reduces the Lipopolysaccharide-Induced Inflammatory Reaction, Peroxynitrite-Mediated Nitration of Proteins, Disruption of the Blood–Brain Barrier, and Damage in the Nigral Dopaminergic System

Tomás-Camardiel, M., Rite, I., Herrera, A. J., de Pablos, R. M., Cano, J., Machado, A., & Venero, J. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.010 · Cited by 203 · see citing works

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

Kühle, J., Gaiottino, J., Leppert, D., Petzold, A., Bestwick, J., Malaspina, A., Lu, C., Dobson, R., Disanto, G., Norgren, N., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307454 · Cited by 197 · see citing works

Role of Microglia in CNS Autoimmunity

Goldmann, T., & Prinz, M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/208093 · Cited by 195 · see citing works

Novel therapeutic targets in depression: Minocycline as a candidate treatment

Soczynska, J. K., Mansur, R. B., Brietzke, E. M., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 190 · see citing works

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Metz, L. M., Li, D. K. B., Traboulsee, A. L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608889 · Cited by 185 · see citing works

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease.

Kalyvas, A., & David, S. (2004) · Neuron · doi:10.1016/s0896-6273(04)00003-0 · Cited by 181 · see citing works

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model

Tsuji, M., Wilson, M. A., Lange, M. S., & Johnston, M. V. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.011 · Cited by 181 · see citing works

Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration

Scholz, R., Sobotka, M., Caramoy, A., Stempfl, T., Moehle, C., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0431-4 · Cited by 177 · see citing works

Minocycline exerts inhibitory effects on multiple mitogen‐activated protein kinases and IκBα degradation in a stimulus‐specific manner in microglia

Nikodémová, M., Duncan, I. D., & Watters, J. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03520.x · Cited by 176 · see citing works

Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis

Metz, L. M., Zhang, Y., Yeung, M., Patry, D. G., Bell, R. B., Stoian, C. A., Yong, V. W., Patten, S. B., Duquette, P., Antel, J. P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20111 · Cited by 171 · see citing works

Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis

Mishra, M. K., & Basu, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05238.x · Cited by 167 · see citing works

Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets

Potts, M. B., Koh, S.-E., Whetstone, W. D., Walker, B. A., Yoneyama, T., Claus, C. P., Manvelyan, H. M., & Noble-Haeusslein, L. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.006 · Cited by 164 · see citing works

Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury

Kövesdi, E., Kamnaksh, A., Wingo, D., Ahmed, F. A. K. M., Grunberg, N. E., Long, J. B., Kasper, C. E., & Agoston, D. V. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00111 · Cited by 160 · see citing works

Minocycline Down-regulates MHC II Expression in Microglia and Macrophages through Inhibition of IRF-1 and Protein Kinase C (PKC)α/βII

Nikodémová, M., Watters, J. J., Jackson, S. J., Yang, S. K., & Duncan, I. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611907200 · Cited by 159 · see citing works

What is behind the non-antibiotic properties of minocycline?

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.006 · Cited by 158 · see citing works

Clinical Potential of Minocycline for Neurodegenerative Disorders

BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · see citing works

Minocycline Confers Early but Transient Protection in the Immature Brain following Focal Cerebral Ischemia—Reperfusion

Fox, C. K., Dingman, A., Derugin, N., Wendland, M. F., Manabat, C., Ji, S., Ferriero, D. M., & Vexler, Z. S. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600121 · Cited by 157 · see citing works

Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination

Li, W., Setzu, A., Zhao, C., & Franklin, R. J. M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.011 · Cited by 155 · see citing works

Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction

Giuliani, F., Hader, W. J., & Yong, V. W. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804477 · Cited by 154 · see citing works

Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

Lopez-Diego, R., & Weiner, H. (2008) · Nature reviews. Drug discovery · doi:10.1038/nrd2358 · Cited by 173 · see citing works

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151 · see citing works

Microglial signalling mechanisms: Cathepsin S and Fractalkine

Clark, A. K., & Malcangio, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.012 · Cited by 149 · see citing works

Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus

Wang, N., Mi, X., Gao, B., Gu, J., Wang, W., Zhang, Y., & Wang, X. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.021 · Cited by 140 · see citing works

Minocycline reduces ethanol drinking

Agrawal, R. G., Hewetson, A., George, C. M., Syapin, P. J., & Bergeson, S. E. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.002 · Cited by 142 · see citing works

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

Morimoto, N., Shimazawa, M., Yamashima, T., Nagai, H., & Hara, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.062 · Cited by 137 · see citing works

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation

Roth, A. D., Ramírez, G., Alarcón, R., & Rommy von Bernhardi, M. (2005) · Biological Research · doi:10.4067/s0716-97602005000400011 · Cited by 131 · see citing works

Minocycline inhibits neuronal death and glial activation induced by β‐amyloid peptide in rat hippocampus

Ryu, J. K., Franciosi, S., Sattayaprasert, P., Kim, S. U., & McLarnon, J. G. (2004) · Glia · doi:10.1002/glia.20051 · Cited by 129 · see citing works

The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting

Correale, J., & Villa, A. (2007) · Autoimmunity · doi:10.1080/08916930601183522 · Cited by 167 · see citing works

Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses

Lee, C., Jeon, S. J., Cho, K. S., Moon, E., Sapkota, A., Jun, H., Ryu, J. H., & Choi, J. W. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0550-2 · Cited by 126 · see citing works

The Potential of Minocycline for Neuroprotection in Human Neurologic Disease

Zemke, D., & Majid, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150867.98887.3e · Cited by 125 · see citing works

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

Zabad, R. K., Metz, L. M., Todoruk, T. R., Zhang, Y., Mitchell, J. R., Yeung, M., Patry, D. G., Bell, R. B., & Yong, V. W. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070319 · Cited by 120 · see citing works

Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury

Kim, J. Y., Kim, N., & Yenari, M. A. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12360 · Cited by 119 · see citing works

Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials

Malhotra, K., Chang, J. J., Khunger, A., Blacker, D., Switzer, J. A., Goyal, N., Hernández, A. V., Pasupuleti, V., Alexandrov, A. V., & Tsivgoulis, G. K. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8935-3 · Cited by 119 · see citing works

Multiple sclerosis: a battle between destruction and repair

McQualter, J., & Bernard, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04232.x · Cited by 120 · see citing works

Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex: Progesterone Receptor and Myelin Repair

El-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116 · see citing works

Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.

Maier, K., Merkler, D., Gerber, J., Taheri, N., Kuhnert, A., Williams, S. K., Neusch, C., Bähr, M., & Diem, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.022 · Cited by 121 · see citing works

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

Opdenakker, G., Nelissen, I., & Damme, J. V. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00587-8 · Cited by 111 · see citing works

Microglia and inflammation: conspiracy, controversy or control?

Fernandes, A. M. A., Miller‐Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 110 · see citing works

Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy

Garwood, C. J., Cooper, J. D., Hanger, D. P., & Noble, W. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00136 · Cited by 106 · see citing works

Additive effect of the combination of glatiramer acetate and minocycline in a model of MS

Giuliani, F., Metz, L. M., Wilson, T., Fan, Y., Bar‐Or, A., & Yong, V. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.006 · Cited by 104 · see citing works

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis

Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H., & Wekerle, H. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0537-7 · Cited by 104 · see citing works

Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers

Wekerle, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.008 · Cited by 101 · see citing works

Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS

Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 101 · see citing works

Gelatinase B/matrix metalloproteinase‐9 cleaves interferon‐β and is a target for immunotherapy

Nelissen, I., Martens, E., den Steen, P. E. V., Proost, P., Ronsse, I., & Opdenakker, G. (2003) · Brain · doi:10.1093/brain/awg129 · Cited by 100 · see citing works

Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice

Heo, K., Cho, Y., Cho, K., Kim, H., Kim, H., Shin, H. Y., Lee, B. I., & Kim, G. W. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.027 · Cited by 97 · see citing works

Minocycline in neurodegenerative and psychiatric diseases: An update

Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · European Journal of Neurology · doi:10.1111/ene.14642 · Cited by 95 · see citing works

Migration of African trypanosomes across the blood–brain barrier

Masocha, W., Rottenberg, M. E., & Kristensson, K. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.045 · Cited by 94 · see citing works

The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage

Owens, T. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073925.19076.f2 · Cited by 94 · see citing works

The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity

Thompson, K. K., & Tsirka, S. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030504 · Cited by 94 · see citing works

The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword

Xu, Y., Li, Y., Wang, C., Han, T., Liu, H., Sun, L., Hong, J., Hashimoto, M., & Wei, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02723-y · Cited by 88 · see citing works

Minocycline Modulates Neuroinflammation Independently of Its Antimicrobial Activity in Staphylococcus aureus-Induced Brain Abscess

Kielian, T., Esen, N., Liu, S., Phulwani, N. K., Syed, M., Phillips, N., Nishina, K. A., Cheung, A. L., Schwartzman, J. D., & Ruhe, J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070231 · Cited by 88 · see citing works

Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial

Sacktor, N., Miyahara, S., Deng, L., Evans, S., Schifitto, G., Cohen, B. A., Paul, R., Robertson, K., Jarocki, B., Scarsi, K., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f0412 · Cited by 87 · see citing works

Therapeutics for neonatal brain injury

Gonzalez, F. F., & Ferriero, D. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.07.003 · Cited by 87 · see citing works

Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase

Siller, S. S., & Broadie, K. S. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008045 · Cited by 86 · see citing works

Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis

Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & de Rosbo, N. K. (2013) · Immunology · doi:10.1111/imm.12177 · Cited by 85 · see citing works

Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease

Yokoyama, H., Kuroiwa, H., Yano, R., & Araki, T. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0986-2 · Cited by 85 · see citing works

Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02066 · Cited by 83 · see citing works

Minocycline decreases in vitro microglial motility, β1‐integrin, and Kv1.3 channel expression

Nutile‐McMenemy, N., Elfenbein, A., & DeLeo, J. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04889.x · Cited by 83 · see citing works

The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus–associated neurological disease: From mechanism to treatment

Clements, J. E., Mankowski, J. L., Gama, L., & Zink, M. C. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802132832 · Cited by 81 · see citing works

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

Wei, X., Zhao, L., Liu, J., Dodel, R. C., Farlow, M. R., & Du, Y. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.014 · Cited by 81 · see citing works

Minocycline inhibits the growth of glioma by inducing autophagy

Liu, W., Lin, C.-H., Hsiao, M., & Gean, P. (2011) · Autophagy · doi:10.4161/auto.7.2.14043 · Cited by 78 · see citing works

Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.

Ryu, J. K., Choi, H. B., & McLarnon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 83 · see citing works

Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion

Cho, K., La, H. O., Cho, Y., Sung, K.-W., & Kim, S.-Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20727 · Cited by 78 · see citing works

Reversible neural stem cell niche dysfunction in a model of multiple sclerosis

Rasmussen, S. O., Imitola, J., Ayuso‐Sacido, Á., Wang, Y., Starossom, S. C., Kivisäkk, P., Zhu, B., Meyer, M., Bronson, R. T., García‐Verdugo, J. M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22299 · Cited by 76 · see citing works

Inflammation: Beneficial or Detrimental After Spinal Cord Injury?

Chan, C. C. M. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488908786242434 · Cited by 76 · see citing works

The prospects of minocycline in multiple sclerosis.

Chen, X.-H., Ma, X.-M., Jiang, Y., Pi, R., Liu, Y.-Y., & Ma, L.-L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.006 · Cited by 75 · see citing works

Decreased iNOS synthesis mediates dexamethasone‐induced protection of neurons from inflammatory injury in vitro

Golde, S., Coles, A. J., Lindquist, J. A., & Compston, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02917.x · Cited by 76 · see citing works

Neuroprotection in the Newborn Infant

Gonzalez, F. F., & Ferriero, D. M. (2009) · Clinics in Perinatology · doi:10.1016/j.clp.2009.07.013 · Cited by 73 · see citing works

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity

Ahuja, M., Bishnoi, M., & Chopra, K. (2007) · Toxicology · doi:10.1016/j.tox.2007.11.003 · Cited by 74 · see citing works

Protecting Neurons

Ferriero, D. M. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00302.x · Cited by 72 · see citing works

Pilot Study of Minocycline in Relapsing-Remitting Multiple Sclerosis

Zhang, Y., Metz, L. M., Yong, V. W., Bell, R. B., Yeung, M., Patry, D. G., & Mitchell, J. R. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100008611 · Cited by 72 · see citing works

Chlortetracycline and Demeclocycline Inhibit Calpains and Protect Mouse Neurons against Glutamate Toxicity and Cerebral Ischemia

Jiang, S. X., Lertvorachon, J., Hou, S., Konishi, Y., Webster, J., Mealing, G. A. R., Brunette, E., Tauskela, J. S., & Preston, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503113200 · Cited by 72 · see citing works

Mechanisms of CNS remyelination—the key to therapeutic advances

Zhao, C., Fancy, S. P. J., Kotter, M., Li, W., & Franklin, R. J. M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.008 · Cited by 72 · see citing works

Improving Outcomes of Neuroprotection by Minocycline

Xue, M., Mikliaeva, E. I., Casha, S., Zygun, D., Demchuk, A. M., & Yong, V. W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090361 · Cited by 71 · see citing works

The prospects of minocycline in multiple sclerosis.

Chen, X.-H., Ma, X.-M., Jiang, Y., Pi, R., Liu, Y.-Y., & Ma, L.-L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.006 · Cited by 75 · see citing works

Potential antibiotic treatment for multiple sclerosis?

Love, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07248-3 · Cited by 6 · see citing works

Minocycline ameliorates CNS autoimmunity through restraint of CD4+CD11bc+ cells

Milosavljević, Z., Lazarević, M. N., Stegnjaić, G., Nikolovski, N., Mirković, K., Lodygin, D., Flügel, A., Miljković, Đ., Stanisavljević, S., & Jevtić, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823730

Targeting leukocyte MMPs and transmigration

Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C. A., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 427 · see citing works

Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord

Nikodémová, M., Lee, J., Fábry, Z., & Duncan, I. D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.009 · Cited by 36 · see citing works